SCHEMBL28255252

SCHEMBL28255252

CC1CC1(N)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27545369 0.80 CYP1A2 (0.39)
Hydrochloric Acid SCHEMBL27468730 0.79 CYP1A2 (0.42)
SCHEMBL27566036 0.77 CYP1A2 (0.37)
SCHEMBL2852278 0.76 CYP1A2 (0.43)
Hydrochloric Acid SCHEMBL27465334 0.76 CYP1A2 (0.36)
SCHEMBL27545570 0.76 CYP1A2 (0.36)
Hydrochloric Acid SCHEMBL2858088 0.76 CYP1A2 (0.47)
SCHEMBL466184 0.74 CYP1A2 (0.43)
SCHEMBL27545389 0.74 CYP1A2 (0.35)
SCHEMBL27448587 0.74 CYP1A2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110016020-A Compound or pharmaceutically acceptable salt thereof, application and pharmaceutical composition thereof 铁木医药有限公司 2019-07-16 CN disclosed
CN-109384778-A Use of a compound or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of a disease, health condition or disorder 铁木医药有限公司 2019-02-26 CN disclosed
CN-109369635-A Compound or pharmaceutically acceptable salt thereof, application and pharmaceutical composition thereof 铁木医药有限公司 2019-02-22 CN disclosed
CN-108912111-A compounds and pharmaceutical compositions 铁木医药有限公司 2018-11-30 CN disclosed
CN-105408328-B sGC stimulators 铁木医药有限公司 2018-11-16 CN disclosed